The company is waiting for approval from the FDA to initiate a Phase IIb clinical trial in traumatic brain injury. Depending on the timing of that approval, the trial could begin in late 2008 or early 2009. It is currently planned to be a multi-center, double-blind, placebo-controlled study that would enroll up to 300 patients

For information on clinical trials that are currently enrolling patients, please visit the following site: http://www.clinicaltrials.gov/